• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHROCARE CORP. PROCISE MAX COBLATOR II; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHROCARE CORP. PROCISE MAX COBLATOR II; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Model Number EICA8898-01
Device Problem Suction Problem (2170)
Patient Problem Injury (2348)
Event Type  Injury  
Event Description
It was reported that during an adenoidectomy, it was reported that the surgeon was unable to successfully ablate down the tissue without massive clogging and bleeding in order to remove the adenoids.The case took over 1.5 hours where it should¿ve taken about 30 minutes.No patient injury was reported.The procedure was completed with a competitor device.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
 
Manufacturer Narrative
The reported device, used in treatment, was not returned to the designated complaint unit for independent evaluation, thus visual inspection and functional testing could not be performed.The impact to the patient beyond the reported bleeding and the procedural delay cannot be determined.Should an additional medical information be provided, this compliant would be re-assessed.Therefore, no further clinical/medical assessment is warranted at this time.No product identification information was provided and thus a manufacturing record review could not be conducted.A complaint history review found related failures; this failure mode will be trended to assess for any necessary corrective actions.A review of the instructions for use found monitor saline flow during procedure.A review of risk management files found that the reported failure was documented appropriately.A relationship, if any, between the subject device and the reported event could not be determined.Please refer to the instructions for use for recommendations on proper use of the device and potential troubleshooting methods to prevent future reoccurrence of the reported event.Factors that could have contributed to the reported event include: not having sufficient saline outflow in order to maintain coagulation or possibly not having sufficient suction which decreases the functionality of the device.If the product associated with this event is returned at a future date, this evaluation will be reopened for investigation.There were no indications that would suggest that the device did not meet product specifications upon release into distribution.Internal complaint reference: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROCISE MAX COBLATOR II
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
ARTHROCARE CORP.
7000 w. william cannon
austin TX 78735
MDR Report Key10694693
MDR Text Key211851919
Report Number3006524618-2020-00894
Device Sequence Number1
Product Code GEI
UDI-Device Identifier00817470003888
UDI-Public00817470003888
Combination Product (y/n)N
PMA/PMN Number
K070374
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,user f
Type of Report Initial,Followup
Report Date 11/25/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEICA8898-01
Device Catalogue NumberEICA8898-01
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received11/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age15 YR
-
-